In addition, a CD99 monoclonal antibody (clone H036 1.1) has been shown to be directly toxic to acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) cells and may be a novel therapeutic approach for the treatment of these myeloid malignancies15. Here, CD99 is linked to acute myeloid leukemia.